NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

ZIVO Bioscience logo
$5.50 0.00 (0.00%)
As of 11/20/2026 11:14 AM Eastern

About ZIVO Bioscience Stock (NASDAQ:ZIVO)

Advanced

Key Stats

Today's Range
$4.94
▼
$5.50
50-Day Range
$3.19
▼
$10.49
52-Week Range
$1.11
▼
$12.04
Volume
243 shs
Average Volume
2,587 shs
Market Capitalization
$23.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ZIVO Bioscience, Inc. is a biotechnology company that develops products based on proprietary algal strains, biomass and bioactive compounds. Its research programs target applications in animal health and human health and wellness.

In animal health, the company has focused on developing an algae-derived feed ingredient for poultry, including research into supporting poultry health. ZIVO has also investigated potential human-health applications for compounds derived from its algae. These are development programs, rather than a broad portfolio of established commercial products.

The company was formerly known as Z Trim Holdings, Inc. and adopted the ZIVO Bioscience name as it shifted its focus toward biotechnology and algae-based research. ZIVO is based in the United States.

AI Generated. May Contain Errors.

Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZIVO Stock News Headlines

Zivo Bioscience Inc. Wt
Your Copy is on Hold (Claim it now)
James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel
ZIVO Bioscience Provides Special Letter to Shareholders
See More Headlines

ZIVO Stock Analysis - Frequently Asked Questions

ZIVO Bioscience's stock was trading at $8.70 at the beginning of the year. Since then, ZIVO shares have decreased by 36.8% and is now trading at $5.50.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) issued its quarterly earnings results on Monday, May, 11th. The biotechnology company reported ($0.06) earnings per share for the quarter. The biotechnology company had revenue of $20 thousand for the quarter.

ZIVO Bioscience's stock reverse split before market open on Friday, October 27th 2023.The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include NIO (NIO), Anglo American (AAL), American Airlines Group (AAL), Abeona Therapeutics (ABEO), Amarin (AMRN), Ares Capital (ARCC) and AST SpaceMobile (ASTS).

Company Calendar

Today
11/22/2026
Next Earnings (Estimated)
12/02/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
CIK
1101026
Fax
N/A
Employees
7
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
($1.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.78 million
Net Margins
N/A
Pretax Margin
-17,113.75%
Return on Equity
N/A
Return on Assets
-2,240.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.17
Quick Ratio
0.17

Sales & Book Value

Annual Sales
$15.85 thousand
Price / Sales
1,462.62
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.81) per share
Price / Book
-6.79

Miscellaneous

Outstanding Shares
4,215,000
Free Float
2,911,000
Market Cap
$23.18 million
Optionable
Not Optionable
Beta
0.30

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:ZIVO) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners